Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (5934)	5/13/1998 2:16:00 PM
From: BARRY ALLEN	Read Replies (3) \| Respond to of 8902

Interesting......this was posted on the Yahoo SNRS board! ********************************************************************* Top:Business and Finance:Stocks:Healthcare:Medical Equipment & Supplies:SNRS (Sunrise Tech. Int'l, Inc.) <- Previous Next -> Message 485 of 501 Reply advr popdsply May 12 1998 9:19PM EDT Investors in ADVR should be excited about the first public forum that ADVR is presenting since 2 years ago. (The American Society of Microbiology) The Barbados preliminary results are very convincing and yet no one seems to have put 2 and 2 together to realize that the final results are being presented in 1 week. Don't say that I didn't alert you to the opportunity to buy at $.36 The last time that ADVR had any media coverage, the stock went from $.30 to $1.90 in 3 days on 12,000,000 shares daily volume. Since 2 years ago, this company has obtained respected research scientists from Mt. Sinai Med. Center among others, has hired numerous PhD's, has attracted the interest of the National Cance Institute (NCI) which has recently renewed its research agreement to study ADVR's flagship drug, RETICULOSE, and has obtained approval from the Argentinian FDA for Phase 3 human clinical trials for AIDS and Human Papilloma Virus (HPV, Genital Warts). For those of you who would like to reference the preliminary results of the Reticulose study, you can link to the following: pslgroup.com For those of you who would like to reference the article from the Journal of Investigative Medicine as reported in Infectious Disease News, which prompted the stock price jump from $.30 to $1.90, you can link to the following: slackinc.com Frankly, the report to be presented at the upcoming Microbiology Society Conference on May 21, is much more impressive and significant. Those of you with access to Silicon Investor, please feel free to re-post on your thread. POP 2 messages.yahoo.com